ConductScience.org, home

Paper · 20161663

B-cell tolerance in transplantation: is repertoire remodeling the answer?

Parsons RF and 6 others. Expert Rev Clin Immunol, 2009. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. B-cell tolerance in transplantation: is repertoire remodeling the answer? Papers, record 20161663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20161663

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
B-cell tolerance in transplantation: is repertoire remodeling the answer?
PubMed
Journal
Expert Rev Clin Immunol
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.29
iCite
Revised in PubMed
2025-05-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parsons RFRonald F
2Vivek KKumar
3Redfield RRRobert R
4Migone TSThi-Sau
5Cancro MPMichael P
6Naji AAli
7Noorchashm HHooman

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K01 DK064603NIDDK NIH HHSUnited StatesK01DK064603PubMedNIH RePORTER
K08 DK064603NIDDK NIH HHSUnited StatesK08DK064603PubMedNIH RePORTER
R01 AI073939NIAID NIH HHSUnited StatesR01AI073939PubMed and NIHNIH RePORTER
R03 DK080286NIDDK NIH HHSUnited StatesR03DK080286PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References193

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117,328,676Molecular mechanisms of antibody somatic hypermutation.Annu Rev Biochem2007https://conductscience.org/library/papers/17328676PubMed
21,827,140Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.J Exp Med1991https://conductscience.org/library/papers/1827140PubMed
316,709,796Space, selection, and surveillance: setting boundaries with BLyS.J Immunol2006https://conductscience.org/library/papers/16709796PubMed
415,502,841Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation.Nat Med2004https://conductscience.org/library/papers/15502841PubMed
519,194,545Successful renal transplantation with desensitization in highly sensitized patients: a single center experience.J Korean Med Sci2009https://conductscience.org/library/papers/19194545PubMed
611,228,414Selection events operating at various stages in B cell development.Curr Opin Immunol2001https://conductscience.org/library/papers/11228414PubMed
719,100,397High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis.Transplant Proc2008https://conductscience.org/library/papers/19100397PubMed
817,496,547Rituximab therapy for acute humoral rejection after kidney transplantation.Transplantation2007https://conductscience.org/library/papers/17496547PubMed
916,508,933Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.Arthritis Rheum2006https://conductscience.org/library/papers/16508933PubMed
1017,450,373Current concepts and perspectives of immunosuppression in organ transplantation.Langenbecks Arch Surg2007https://conductscience.org/library/papers/17450373PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
34,633,538The Positive Impact of Donor Bone Marrow Cells Transplantation into Immunoprivileged Compartments on the Survival of Vascularized Skin Allografts.Arch Immunol Ther Exp (Warsz)2021https://conductscience.org/library/papers/34633538PubMed
22,330,846Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment.Immunol Lett2012https://conductscience.org/library/papers/22330846PubMed
21,982,511Essential role for B cells in transplantation tolerance.Curr Opin Immunol2011https://conductscience.org/library/papers/21982511PubMed
20,655,723B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.Transplant Rev (Orlando)2010https://conductscience.org/library/papers/20655723PubMed
20,631,877The role of B cells in transplantation and immunopathic diseases.Immune Netw2010https://conductscience.org/library/papers/20631877PubMed

Genes42

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20161663

GET https://conductscience.org/api/papers/v1/20161663/references?page=2